Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad

NCT05428592 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: LVRNA009
BIOLOGICAL: CoronaVac®

Sponsor

AIM Vaccine Co., Ltd.